AEterna Zentaris (AEZS)
(Real Time Quote from BATS)
$6.11 USD
+0.11 (1.83%)
Updated Jul 16, 2024 01:40 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
AEterna Zentaris Inc. [AEZS]
Reports for Purchase
Showing records 141 - 160 ( 168 total )
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
108 ENDOMETRIAL DATA 4Q10 - PERIFOSINE DEAL FOR ASIA OR EU SOUGHT
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Cash Bolstered - Positive EMA Advice for Perifosine in CRC - Full Steam Ahead
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
R&R?s Week in Review: Oncology and Stem Cell Sectors
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Perifosine Demonstrates Potential in Pediatric Neuroblastoma Study
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Perifosine Demonstrates Potential in Pediatric Neuroblastoma Study
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
1Q10 -108 IND APPROVED IN BLADDER CANCER - OVARIAN DATA AT ASCO
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
1Q10 - AEZS-108 IND APPROVED IN BLADDER CANCER - OVARIAN DATA AT ASCO
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.